Compounds > lek 8829
Page last updated: 2024-08-02 07:51:22

lek 8829

Description

LEK 8829: structure given in first source; RN given refers to monomethanesulfonate salt [MeSH]

Cross-References

ID SourceID
PubMed CID9796528
SCHEMBL ID13590718
MeSH IDM0238151

Synonyms (7)

Synonym
lek 8829
145204-78-0
lek-8829
160161-67-1
SCHEMBL13590718
DTXSID80166810
n-[[(6ar,9s)-7-methyl-6,6a,8,9-tetrahydro-4h-indolo[4,3-fg]quinolin-9-yl]methyl]-n-methylprop-2-yn-1-amine

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's4 (66.67)18.2507
2000's2 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
SubstanceStudiesClassesRolesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
sk&f 82958
1
benzazepine1999199925.0low001000
ibotenic acid
1
non-proteinogenic alpha-amino acidneurotoxin1999199925.0low001000
haloperidol
4
aromatic ketone;
hydroxypiperidine;
monochlorobenzenes;
organofluorine compound;
tertiary alcohol		antidyskinesia agent;
antiemetic;
dopaminergic antagonist;
first generation antipsychotic;
serotonergic antagonist		1994199927.2medium004000
oxidopamine
2
benzenetriol;
catecholamine;
primary amino compound		drug metabolite;
human metabolite;
neurotoxin		1996200225.0low001100
pindolol
1
indoles;
secondary amine		antiglaucoma drug;
antihypertensive agent;
beta-adrenergic antagonist;
serotonergic antagonist;
vasodilator agent		1996199628.0low001000
spiperone
1
aromatic ketone;
azaspiro compound;
organofluorine compound;
piperidines;
tertiary amino compound		alpha-adrenergic antagonist;
antipsychotic agent;
dopaminergic antagonist;
psychotropic drug;
serotonergic antagonist		1994199430.0low001000
apomorphine
1
aporphine alkaloidalpha-adrenergic drug;
antidyskinesia agent;
antiparkinson drug;
dopamine agonist;
emetic;
serotonergic drug		1996199628.0low001000
bromocriptine
2
indole alkaloidantidyskinesia agent;
antiparkinson drug;
dopamine agonist;
hormone antagonist		1998199925.5low002000
quinpirole
1
pyrazoloquinolinedopamine agonist2002200222.0low000100
cocaine
1
benzoate ester;
methyl ester;
tertiary amino compound;
tropane alkaloid		adrenergic uptake inhibitor;
central nervous system stimulant;
dopamine uptake inhibitor;
environmental contaminant;
local anaesthetic;
mouse metabolite;
plant metabolite;
serotonin uptake inhibitor;
sodium channel blocker;
sympathomimetic agent;
vasoconstrictor agent;
xenobiotic		2004200420.0low000100
ergoline
1
diamine;
ergoline alkaloid;
indole alkaloid fundamental parent;
indole alkaloid;
organic heterotetracyclic compound		1994199430.0low001000
neurotensin
1
peptide hormonehuman metabolite;
mitogen;
neurotransmitter;
vulnerary		2002200222.0low000100
lysergic acid
6
1994200425.2high004200
clozapine
1
benzodiazepine;
N-arylpiperazine;
N-methylpiperazine;
organochlorine compound		adrenergic antagonist;
dopaminergic antagonist;
EC 3.4.21.26 (prolyl oligopeptidase) inhibitor;
environmental contaminant;
GABA antagonist;
histamine antagonist;
muscarinic antagonist;
second generation antipsychotic;
serotonergic antagonist;
xenobiotic		1994199430.0low001000
ConditionIndicatedStudiesFirst YearLast YearAverage AgeRelationship StrengthTrialspre-19901990's2000's2010'spost-2020
Anochlesia0
1
1994199430.0medium001000
Cocaine Abuse0
1
2004200420.0medium000100
Cocaine-Related Disorders0
1
2004200420.0medium000100
Disease Models, Animal0
2
2002200421.0high000200